Study guide
11.1 Acute Upper Airway Obstruction (Croup, Epiglottitis, Bacterial Tracheitis, Foreign Body)
Neonatal Pediatric Transport C-NPT
Track your progress as you read
Finished sections get a check mark.
1 Introduction: The C-NPT Exam
About the C-NPT Exam: 2026 Format, Eligibility & Content Outline
2 Chapter 1: Transport Systems, Regulatory Framework & Legal Issues
1.1 Transport System Architecture, Accreditation (CAMTS) & Dispatch Triage 1.2 Regulatory & Legal Mandates: EMTALA, HIPAA, Consent & Documentation 1.3 Medical Direction, Scope of Practice & Ethical Considerations
3 Chapter 2: Safety, Communication, Crew Resource Management & Transport Environment
2.1 Crew Resource Management (CRM), Situational Awareness & Sterile Cockpit 2.2 Aircraft & Ground Ambulance Operations, Landing Zones & Vehicle Dynamics 2.3 Environmental Hazards, Weather Minimums & In-Flight Emergency Procedures 2.4 Communication in Transport: Peer Handoffs, Age-Appropriate Care, Families & Crew Stressors 2.5 Infection Control, PPE, Scene Safety & Disaster/Evacuation Planning
4 Chapter 3: Flight Physiology & Environmental Stressors
3.1 Physical Gas Laws & Transport Implications (Boyle, Dalton, Charles, Henry, Graham) 3.2 Altitude Hypoxia, Barometric Pressure Changes & Dysbarism 3.3 Acceleration Forces (G-forces), Vibration & Acoustic Stress in Transit 3.4 Thermoregulation Physics & Neutral Thermal Environment in Transit
5 Chapter 4: Invasive Procedures & Transport Monitoring
4.1 Advanced Airway Management & Endotracheal Intubation in Transit 4.2 Pleural Decompression (Needle Thoracostomy & Chest Tube Management) 4.3 Vascular Access: Umbilical Lines (UAC/UVC), Intraosseous (IO) & Arterial Lines
6 Chapter 5: Transport Equipment, Respiratory Physiology & Mechanical Ventilation
5.1 Transport Incubators (Isolettes), Thermal Control & Electrical/Gas Power Systems 5.2 Portable Ventilators & Modes (PC, VC, PRVC, High Frequency) 5.3 Gas Cylinder Duration Calculations, Oxygen Delivery & Inhaled Nitric Oxide (iNO) 5.4 Respiratory Physiology: Acid-Base Balance, Oxygenation, Lung Mechanics & Troubleshooting
7 Chapter 6: Transport Pharmacology, Resuscitation, Fluids & Electrolytes
6.1 Vasoactive Infusions & Inotropes (Epinephrine, Dopamine, Dobutamine, Milrinone) 6.2 Sedation, Analgesia & Neuromuscular Blockade in Transport 6.3 Prostaglandin E1 (Alprostadil) & Surfactant Replacement Therapy 6.4 Resuscitation Protocols (NRP, PALS) & Shock Fluid Resuscitation 6.5 Antimicrobial Pharmacology in Neonatal & Pediatric Transport 6.6 Post-Resuscitation Care, Defibrillation & Cardioversion in Transit, ECMO Indications & the Transport-vs-Stay Decision 6.7 Fluid & Electrolyte Therapy Across the Ages: Maintenance, Dehydration, Fluid Overload & Electrolyte Emergencies
8 Chapter 7: Neonatal Respiratory Pathologies & Management
7.1 Respiratory Distress Syndrome (RDS) & Surfactant Deficiency 7.2 Meconium Aspiration Syndrome (MAS) & Persistent Pulmonary Hypertension (PPHN) 7.3 Transient Tachypnea (TTN), Neonatal Pneumothorax & Congenital Diaphragmatic Hernia (CDH) 7.4 Neonatal Upper Airway Anomalies, Aspiration, Pneumonia, Chronic Lung Disease & Respiratory Failure
9 Chapter 8: Neonatal Cardiovascular Critical Care
8.1 Ductal-Dependent Cyanotic Congenital Heart Defects (TGA, TOF, Tricuspid Atresia) 8.2 Ductal-Dependent Systemic Blood Flow Lesions (HLHS, Coarctation, Interrupted Arch) 8.3 Neonatal Arrhythmias, Cardiogenic Shock & Post-Resuscitation Care 8.4 Acyanotic Congenital Heart Lesions, Patent Ductus Arteriosus, Obstructed TAPVR & Neonatal Heart Failure
10 Chapter 9: Neonatal Neurological & Metabolic Crises
9.1 Hypoxic-Ischemic Encephalopathy (HIE) & Passive/Active Therapeutic Hypothermia 9.2 Neonatal Seizures & Intraventricular Hemorrhage (IVH) 9.3 Neonatal Hypoglycemia, Electrolyte Derangements & Hyperbilirubinemia 9.4 Subgaleal Hemorrhage, Neonatal Sepsis & Meningitis, and Perinatal Substance Exposure (NOWS)
11 Chapter 10: Neonatal Surgical Emergencies, Neural Tube Defects & ELBW Care
10.1 Abdominal Wall Defects (Gastroschisis vs. Omphalocele) & TEF/Esophageal Atresia 10.2 Necrotizing Enterocolitis (NEC), Malrotation with Volvulus & Intestinal Obstruction 10.3 Care of the Extremely Low Birth Weight (ELBW) Infant (<1000g) in Transit 10.4 Neural Tube Defects: Myelomeningocele, Encephalocele & Transport of the Newborn With an Open Spinal Defect
12 Chapter 11: Pediatric Respiratory Emergencies
11.1 Acute Upper Airway Obstruction (Croup, Epiglottitis, Bacterial Tracheitis, Foreign Body) 11.2 Lower Airway Crises: Status Asthmaticus & Severe Bronchiolitis 11.3 Pediatric Acute Respiratory Distress Syndrome (PARDS) & Severe Pneumonia
13 Chapter 12: Pediatric Shock & Cardiovascular Crises
12.1 Pathophysiology & Transport Management of Pediatric Septic Shock 12.2 Hypovolemic, Cardiogenic & Anaphylactic Shock in Children 12.3 Pediatric Cardiac Emergencies: SVT, Ventricular Arrhythmias & Myocarditis 12.4 Pediatric Cardiovascular Crises: Palliated Congenital Heart Disease, Pulmonary Hypertensive Crisis, Pericarditis & Tamponade, Hypertensive Emergency & Anterior Mediastinal Mass
14 Chapter 13: Pediatric Neurological Emergencies & Trauma
13.1 Status Epilepticus, Altered Mental Status & Meningitis/Encephalitis 13.2 Pediatric Traumatic Brain Injury (TBI) & Increased Intracranial Pressure (ICP) 13.3 Blunt/Penetrating Trauma, Spinal Motion Restriction & Thermal Burns 13.4 Non-Accidental Trauma, Smoke Inhalation (Carbon Monoxide & Cyanide) & Heat Illness
15 Chapter 14: Pediatric Toxicological, Environmental & Endocrine Emergencies
14.1 Common Pediatric Toxic Ingestions, Poisonings & Antidotes 14.2 Diabetic Ketoacidosis (DKA) & Environmental Emergencies (Submersion, Hypothermia) 14.3 Button Battery & Foreign-Body Ingestions, Bites & Envenomations, and Hazardous-Material Exposures
16 Chapter 15: Pediatric Metabolic & Hematologic Emergencies
15.1 Anemia, Sickle Cell Disease, Coagulopathies & Blood Product Administration 15.2 Oncologic Emergencies, Acute Kidney Injury & Pediatric Electrolyte Crises
11.1 Acute Upper Airway Obstruction (Croup, Epiglottitis, Bacterial Tracheitis, Foreign Body)
Key Takeaways Explain This Topic AI
Poiseuille's Law dictates that resistance to laminar airflow is inversely proportional to the radius to the fourth power (R ∝ 1/r⁴); in an infant's 4 mm subglottic airway, just 1 mm of circumferential edema increases resistance 16-fold (1,600%) and reduces cross-sectional luminal area by 75%.
Viral croup (laryngotracheobronchitis) is characterized by subglottic mucosal edema, a barking seal cough, and a subglottic 'steeple sign' on AP radiograph; medical management requires dexamethasone (0.6 mg/kg) and nebulized racemic epinephrine (0.5 mL 2.25%) with a mandatory 2-to-4 hour observation window for rebound stridor.
Acute epiglottitis is a rapidly progressive supraglottic bacterial cellulitis presenting with high fever, toxic appearance, drooling, dysphagia, dysphonia, and tripod positioning; transport teams must enforce a strict zero-agitation policy, avoid oropharyngeal instrumentation or IV starts, and transfer directly to an operating room for airway control by anesthesia and ENT.
Bacterial tracheitis ('toxic croup') produces thick purulent tracheal exudates and sloughed pseudomembranes that fail to respond to racemic epinephrine and corticosteroids, presenting an extreme hazard of sudden luminal occlusion that demands emergent intubation and bronchoscopic suctioning.
Under the 2025 AHA guidelines, severe foreign body airway obstruction in a responsive infant is treated with cycles of 5 back blows and 5 chest thrusts (heel of one hand), and in a responsive child with cycles of 5 back blows and 5 abdominal thrusts; blind finger sweeps are strictly prohibited, and direct laryngoscopy with Magill forceps is indicated if the patient becomes unresponsive.
Last updated: September 2026
Acute Upper Airway Obstruction: Croup, Epiglottitis, Bacterial Tracheitis, and Foreign Body Airway Obstruction
Acute upper airway obstruction in pediatric patients constitutes an immediate threat to life. Anatomical differences make infants and young children extraordinarily susceptible to rapid decompensation. Successful interfacility transport hinges upon understanding the underlying pathophysiology, recognizing pathognomonic physical signs, avoiding clinical maneuvers that provoke airway collapse, and executing definitive rescue interventions.
Anatomical Vulnerabilities & Poiseuille's Law of Airway Resistance
The pediatric airway is not merely a miniaturized adult airway; it possesses distinct anatomical and geometric characteristics that heighten vulnerability to obstruction:
Funnel-Shaped Airway: In infants and young children, the airway is funnel-shaped (conical), with the narrowest non-distensible point located at the nondistensible cricoid cartilage ring (subglottic space), unlike the adult airway where the narrowest point is the glottic opening (vocal cords).
Large Cranium & Occiput: A prominent occiput forces the neck into passive flexion when the child lies supine on a flat stretcher, spontaneously occluding the pharyngeal airway unless a small shoulder roll is placed beneath the upper torso.
Macroglossia & Cephalad Larynx: Relative to oral cavity volume, the pediatric tongue is disproportionately large. The larynx sits higher and more anteriorly in the neck (at the level of C3–C4 in infants versus C4–C5 in adults), and the epiglottis is long, narrow, floppy, and U- or omega-shaped, projecting obliquely over the laryngeal inlet.
Mathematical Mechanics of Poiseuille's Law
Resistance ( R R R ) to laminar airflow through a cylindrical conduit is governed by Poiseuille's Law , which states that resistance is inversely proportional to the fourth power of the internal airway radius ( r r r ): R ∝ 8 η l π r 4 R \propto \frac{8\eta l}{\pi r^4} R ∝ π r 4 8 η l
In a healthy neonate or infant with a baseline subglottic diameter of 4 mm ( r = 2 mm r = 2\text{ mm} r = 2 mm ), just 1 mm of circumferential mucosal edema reduces the luminal diameter to 2 mm ( r = 1 mm r = 1\text{ mm} r = 1 mm ).
Resistance Impact: Calculating the fold-increase in resistance: ( r 1 / r 2 ) 4 = ( 2 / 1 ) 4 = 16 / 1 = 16 -fold increase (r_1 / r_2)^4 = (2 / 1)^4 = 16 / 1 = 16\text{-fold increase} ( r 1 / r 2 ) 4 = ( 2/1 ) 4 = 16/1 = 16 -fold increase (a 1,600% increase in airflow resistance).
Cross-Sectional Area Impact: Luminal area ( A = π r 2 A = \pi r^2 A = π r 2 ) drops from π ( 2 ) 2 = 4 π \pi(2)^2 = 4\pi π ( 2 ) 2 = 4 π to π ( 1 ) 2 = 1 π \pi(1)^2 = 1\pi π ( 1 ) 2 = 1 π , representing an acute 75% reduction in cross-sectional area .
By contrast, in an adult with an 8 mm airway ( r = 4 mm r = 4\text{ mm} r = 4 mm ), 1 mm of circumferential edema narrows the diameter to 6 mm ( r = 3 mm r = 3\text{ mm} r = 3 mm ), increasing resistance by only ( 4 / 3 ) 4 ≈ 3.16 -fold (4 / 3)^4 \approx 3.16\text{-fold} ( 4/3 ) 4 ≈ 3.16 -fold (316%). This physical law explains why minor inflammatory swelling precipitates catastrophic stridor and respiratory failure in toddlers.
Viral Laryngotracheobronchitis (Croup)
Viral croup is the most prevalent cause of acute infectious upper airway obstruction in children aged 6 months to 3 years (peaking in the second year of life).
Etiology: Parainfluenza viruses (primarily types 1 and 2) account for over 75% of cases. Other culprits include respiratory syncytial virus (RSV), adenovirus, and influenza A/B.
Pathophysiology: Viral invasion incites mucosal inflammation, hyperemia, and localized edema strictly within the subglottic trachea. Because the rigid cricoid ring cannot expand outward, swelling expands inward, compressing the subglottic lumen.
Clinical Features: Follows a 1-to-3-day viral prodrome of low-grade fever, rhinorrhea, and pharyngitis. The child abruptly develops a harsh, metallic "barking seal" cough , hoarse phonation, and inspiratory stridor that typically intensifies at night and with agitation.
Radiography: Anteroposterior (AP) soft-tissue neck radiograph displays symmetrical tapering of the subglottic airway column, famously designated the "steeple sign" (or "pencil-point sign"). However, diagnosis is primarily clinical, and radiography must never delay emergency therapy.
The Westley Croup Score
The Westley score standardizes clinical severity:
- Inspiratory Stridor: None (0), with agitation (1), at rest (2)
- Retractions: None (0), mild (1), moderate (2), severe (3)
- Air Entry: Normal (0), decreased (1), severely decreased (2)
- Cyanosis: None (0), with agitation (4), at rest (5)
- Level of Consciousness: Normal (0), disoriented/lethargic (5)
Severity Categories: Mild (≤ 2), Moderate (3–5), Severe (6–11), Impending Respiratory Failure (≥ 12).
Pharmacotherapy & The Racemic Epinephrine Rebound Window
Dexamethasone: Administer 0.6 mg/kg orally, IV, or IM (maximum 16 mg ). Dexamethasone reduces subglottic capillary permeability and cellular inflammation. It has an onset of action of 1 to 2 hours and an extended biological half-life of 36 to 72 hours . A single dose is effective for mild, moderate, and severe croup.
Nebulized Racemic Epinephrine: Administer 0.5 mL of a 2.25% solution diluted in 3 mL of normal saline (or 5 mL of standard 1:1,000 [1 mg/mL] L-epinephrine ) delivered via nebulizer or blow-by mask.
Mechanism: Alpha-1 adrenergic stimulation induces profound precapillary arteriolar vasoconstriction in the subglottic mucosa, rapidly shrinking interstitial edema and expanding the airway diameter within 10 to 30 minutes .
Return of Symptoms ('Rebound'): The effect of racemic epinephrine wears off within about 2 hours , and stridor and retractions can return as it does. Studies suggest symptoms usually return toward the pre-treatment baseline rather than becoming worse, but a child whose underlying edema is progressing can deteriorate.
Transport Mandate: Children receiving racemic epinephrine must be observed for a minimum mandatory period of 2 to 4 hours post-administration before determining disposition or embarking on transport. Transport teams must carry readily accessible racemic epinephrine and nebulizer kits in the aircraft or ambulance cabin for immediate redosing if stridor returns in transit.
Acute Epiglottitis (Supraglottitis)
Acute epiglottitis is a fulminant, life-threatening bacterial cellulitis of the supraglottic structures, including the epiglottis, arytenoids, aryepiglottic folds, and vallecula.
Etiology: Historically driven by Haemophilus influenzae type b (Hib) in toddlers aged 2 to 6 years. With widespread Hib vaccination, the overall incidence has decreased, and cases now occur across older children and adolescents, driven by Streptococcus pneumoniae , Group A Streptococcus ( Streptococcus pyogenes ), and Staphylococcus aureus (including MRSA).
Clinical Hallmarks: Abrupt onset (often within 6 to 12 hours) of high fever (> 39°C), toxic appearance, severe odynophagia, refusal to swallow, and active drooling . Phonation is muffled with a characteristic "hot potato" voice (dysphonia), but a barking cough is characteristically absent .
Postural Sign: The child spontaneously assumes the "tripod position" (sitting upright, leaning forward, hands braced on knees, neck hyperextended, and chin thrust forward in the "sniffing" posture) to physically maximize supraglottic airway patency.
Radiography: Lateral soft tissue neck X-ray reveals a massive, swollen, rounded epiglottic shadow projecting into the hypopharynx, known as the "thumbprint sign" .
Transport Safety: The "Zero Agitation" Mandate
In suspected epiglottitis, ANY AGITATION CAN TRIGGER COMPLETE, FATAL AIRWAY OBSTRUCTION . Crying increases turbulent airflow, driving dramatic negative intrathoracic pressures that suck the swollen, redundant supraglottic tissues downward into the laryngeal inlet, causing sudden asphyxiation.
Transport Protocol: Strict Zero-Agitation Rules for Epiglottitis
Never Inspect the Oropharynx: Do NOT depress the tongue with a tongue blade or examine the posterior pharynx; direct stimulation precipitates immediate fatal laryngospasm.
Avoid Noxious Procedures: Defer intravenous line placement, blood draws, and rectal temperatures until the airway is surgically secured.
Preserve Position of Comfort: Allow the child to remain upright in the caregiver's lap. Never force the child supine on a transport cot.
Passive Oxygen Delivery: Provide humidified oxygen via passive blow-by tubing held gently near the face by the caregiver.
Direct Transfer to Operating Room: Transport directly to a tertiary pediatric operating room with advance mobilization of pediatric anesthesiology and pediatric otolaryngology (ENT). Definitive airway control requires controlled inhalational induction (sevoflurane) in the OR, rigid bronchoscopy, and endotracheal intubation using an ETT 0.5 to 1.0 mm smaller than age-predicted size, with surgical tracheostomy instruments open at the bedside.
Bacterial Tracheitis (Pseudomembranous Croup)
Bacterial tracheitis is an acute, invasive bacterial infection of the subglottic tracheal mucosa, frequently developing as a secondary bacterial superinfection following viral croup or influenza.
Microbiology: Staphylococcus aureus (most common), Streptococcus pneumoniae , Moraxella catarrhalis , and Group A Streptococcus .
Pathophysiology: Intense bacterial proliferation produces mucosal necrosis, diffuse ulceration, copious thick purulent secretions, and dense, fibrinous pseudomembranes that loosely adhere to the tracheal wall.
Clinical Distinction: Presents as a child with apparent viral croup who suddenly develops high fever, toxic prostration, severe biphasic stridor (both inspiratory and expiratory), and thick, copious secretions that are completely refractory to nebulized racemic epinephrine and dexamethasone .
Transport Management: Sloughed pseudomembranes present an extreme hazard of sudden luminal tracheal occlusion. Transport teams must prepare for immediate endotracheal intubation under direct laryngoscopy. Once intubated, aggressive tracheal suctioning and bronchoscopic toilet are vital to clear purulent membranes. Empiric broad-spectrum parenteral therapy ( Ceftriaxone 50 mg/kg IV + Vancomycin 15 mg/kg IV ) must be initiated without delay.
Foreign Body Airway Obstruction (FBAO)
Foreign body aspiration occurs most commonly in children aged 1 to 3 years due to immature dentition, oral exploratory behavior, and incomplete coordination of swallowing and laryngeal closure. Common aspirated materials include peanuts, grapes, hot dogs, coins, and small toy parts.
Pathophysiology: Foreign bodies typically lodge in the larynx, trachea, or right mainstem bronchus (which has a steeper angle and wider diameter than the left). Obstruction may be complete, or partial with a ball-valve mechanism where air enters around the object during inspiration (negative intrathoracic pressure widens airways) but becomes trapped during expiration (positive pressure narrows airways).
Clinical Signs: Sudden, witnessed choking, paroxysmal coughing, gagging, or cyanosis while eating or playing, followed by focal unilateral wheezing, asymmetrical chest expansion, and unilaterally diminished breath sounds without prior fever or URI prodrome.
Imaging: Bilateral decubitus or inspiratory-expiratory chest radiographs demonstrate unilateral air trapping (hyperinflation, hyperlucency, and mediastinal shift away from the affected side during expiration) or localized atelectasis.
Transport Resuscitation Algorithm for FBAO
Responsive Infant (< 1 year old): Support the infant prone along the rescuer's forearm with the head angled downward; deliver 5 firm back blows (slaps) between the scapulae. Turn the infant supine and deliver 5 chest thrusts with the heel of one hand over the lower half of the sternum (2025 AHA). Repeat until the object is dislodged or the infant loses consciousness. Never perform blind finger sweeps , which can push the foreign body deeper into the subglottic space.
Responsive Child (> 1 year old): The 2025 AHA guidelines use repeated cycles of 5 back blows followed by 5 abdominal thrusts (inward and upward, from behind the child) until the object is expelled or the child becomes unresponsive.
Unresponsive Pediatric Patient: Lower the patient to the stretcher, activate emergency support, and initiate high-quality CPR starting with chest compressions. Each time the airway is opened to deliver breaths, look inside the mouth; if the foreign object is directly visualized, gently retrieve it. If ventilation remains impossible, perform direct laryngoscopy immediately and use Magill forceps to grasp and extract the foreign body under direct vision.
Diagnostic Differential of Acute Upper Airway Obstruction
Clinical Parameter Viral Croup (Laryngotracheobronchitis) Acute Epiglottitis (Supraglottitis) Bacterial Tracheitis Foreign Body Airway Obstruction
Primary Etiology Parainfluenza virus (types 1, 2) H. influenzae type b, Strep , S. aureus Staphylococcus aureus , S. pneumoniae Food items (nuts, hot dogs), small toys
Typical Age 6 months to 3 years 2 to 6+ years (and older) 1 to 8 years 1 to 3 years
Onset & Prodrome Gradual (1–3 days of viral URI) Rapid (< 12 hours), fulminant Progressive or sudden toxic deterioration Sudden, acute choking while eating/playing
Fever & Appearance Low-grade fever; non-toxic High fever (> 39°C); toxic, ashen High fever; toxic, septic appearance Afebrile; distressed or unresponsive
Stridor & Cough Inspiratory stridor; barking seal cough Soft inspiratory stridor; cough absent Harsh biphasic stridor; weak/painful cough Inspiratory or expiratory; violent cough
Posture & Secretions Normal posture; swallows saliva Tripod/sniffing posture; copious drooling Variable posture; thick purulent sputum Variable; struggling to breathe
Radiographic Sign AP neck: Subglottic "steeple sign" Lateral neck: Supraglottic "thumbprint sign" Ragged tracheal border, pseudomembranes Expiratory air trapping, mediastinal shift
Response to Racemic Epi Excellent (rapid resolution of edema) Negligible / No response Negligible / No response None (mechanical obstruction)
Key Transport Priority Dexamethasone; observe 2–4h for rebound Zero agitation; blow-by O2; direct to OR Urgent intubation, suctioning, antibiotics Back blows/chest thrusts; Magill forceps
Realistic Transport Scenario: In-Flight Rebound Croup Following Racemic Epinephrine
A critical care transport team is dispatched via rotor-wing aircraft to transfer an 18-month-old child (weight 11 kg) with severe croup from a community emergency center to a pediatric ICU. At the referring hospital, the patient presented with Westley Croup Score of 8 (stridor at rest, marked retractions, decreased air entry). The referring physician administered 0.5 mL of 2.25% racemic epinephrine via nebulizer and 6.6 mg of dexamethasone IV. Within 30 minutes, the child's stridor vanished, retractions resolved, and room air SpO2 stabilized at 98%.
Seventy-five minutes later, while cruising at 2,500 feet above ground level, the child awakens, cries, and abruptly develops severe harsh inspiratory stridor, suprasternal retractions, and agitation. Pulse oximetry falls to 89% on room air, and heart rate accelerates to 175 bpm. The transport nurse recognizes racemic epinephrine rebound phenomenon due to waning alpha-adrenergic vasoconstriction. The team immediately connects a second dose of 0.5 mL racemic epinephrine (in 3 mL normal saline) to an in-line nebulizer powered by 6 L/min oxygen. The nurse delivers blow-by nebulization while the flight paramedic positions the child upright on the mother's lap. Within 15 minutes, the stridor softens, retractions remit, and SpO2 recovers to 97%, allowing uneventful arrival at the tertiary center without invasive airway placement.
Clinical Pearls for Pediatric Upper Airway Obstruction
Important
The Exponential Penalty of Poiseuille's Law: Resistance increases inversely with the fourth power of the radius (R ∝ 1/r⁴). In an infant with a 4 mm subglottic lumen, 1 mm of edema reduces the radius by half, magnifying resistance 16-fold (1,600%) and cutting cross-sectional area by 75%.
Warning
Zero Agitation in Epiglottitis: In suspected epiglottitis, never use a tongue blade, never force the patient supine, and never attempt peripheral IV access prior to controlled OR transfer. Agitation can precipitate immediate total airway obstruction.
Note
The Racemic Epinephrine Rebound Clock: Racemic epinephrine works within 10 to 30 minutes but wears off within 90 to 120 minutes. Patients must be monitored for a mandatory 2 to 4 hours post-nebulization. Always verify that replacement doses are in your transport pack prior to departure.